from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3535c/hsaG

LFCtreatmentdescriptionclass of inhibitor

-0.183

Amikacinug/mL Amikacintranslation

-0.178

Cap5-10ug/mL Capreomycintranslation

0.200

Rox10-50 ug/mL Roxithromycintranslation

-0.334

SM2-5 ug/mL Streptomycintranslation

-0.078

Tet5-10 ug/mL Tetracyclinetranslation

0.392

Rif0.2-5ug/mL Rifampicintranscription

0.419

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.394

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.438

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.846

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.681

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.263

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.049

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.862

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.998

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.293

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.398

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.774

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.371

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.783

KCN5-20 ug/mL Potassium cyaniderespiration

-0.027

NaN30.2-2 mM Sodium aziderespiration

0.173

Nigericin50 uM Nigericinrespiration

0.355

TRC10-150 ug/mL Triclosanrespiration

0.587

TRZ10-25 ug/mL Thioridazinerespiration

1.594

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.452

menadione6-10 ug/mL Menadionerespiration

1.244

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.782

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.409

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.617

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.884

NRP_1Non-replicating persistence stage 1dosRassociated

-0.401

Amp0.2mg/mL AmpicillincellWall

-0.546

Cephalexin20-100 ug/mL CephalexincellWall

-0.193

Cerulenin0.32-5 ug/mL CerulenincellWall

0.032

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.301

EMB10-20 ug/mL EthambutolcellWall

-0.389

Eta12-40 ug/mL EthionamidecellWall

-0.522

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.010

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.740

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.312

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.043

BZA0.12 mg/mL BenzamidearomaticAmides

-0.181

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.097

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.007

H2O24 mM hydrogen peroxideDNAdamaging

-0.019

Levo10 ug/mL LevofloxacinDNAdamaging

-0.763

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.990

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.044

UVUV-irradiationDNAdamaging

0.994

ARP41-4 ug/mL Antitubercular compound ARP4?

0.229

Antimycin12.5-50 ug/mL Antimycin A?

-0.414

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.572

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.232

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.187

PA8240.2-2 ug/mL PA-824?

0.892

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.138

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.463

Verapamil50 uM Verapamil?

-0.142

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.705

methoxatin10-20 ug/mL Methoxatin?